Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1987 Feb;31(2):135–138. doi: 10.1128/aac.31.2.135

Clinical study evaluating efficacy of praziquantel in clonorchiasis.

B G Yangco, C De Lerma, G H Lyman, D L Price
PMCID: PMC174677  PMID: 3551827

Abstract

In 74 patients with clonorchiasis, the efficacy and safety of praziquantel was evaluated in a two-phase study: a double-blind, randomized controlled trial of praziquantel versus placebo (42 patients) and an open study (32 patients). All but one of the patients were Laotians. The intensity of clonorchiasis was light in 85% (63 of 74) and moderate in 15% (11 of 74) of the patients. Cure based on our established criteria was noted in 67 of 67 patients (100%) treated with praziquantel at a dose of 75 mg/kg per day. In contrast, four patients (20%) in the placebo group, each with light infection, ceased passing eggs and were, according to our established protocol, considered spontaneous cures (P less than 0.0001). Adverse effects of praziquantel were transient and included nausea and vomiting (15%), vertigo (12%), hepatomegaly (4.5%), headache (1.5%), rash (1.5%), and hypotension (1.5%). Of 20 patients who received placebo, 1 (5%) developed transient skin rash, fever, and chills. Clinically minor and transient, but statistically significant, changes in hemoglobin, total protein in serum, and levels of uric acid, cholesterol, and bilirubin in serum were noted. Results of this study showed that praziquantel is safe, well tolerated, and effective and should be considered as the drug of choice for treatment of clonorchiasis. In moderate infections, a second course of praziquantel therapy may be necessary to eliminate infection.

Full text

PDF
135

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arfaa F. Intestinal parasites among Indochinese refugees and Mexican immigrants resettled in Contra Costa County, California. J Fam Pract. 1981 Feb;12(2):223–226. [PubMed] [Google Scholar]
  2. Davis A., Wegner D. H. Multicentre trials of praziquantel in human schistosomiasis: design and techniques. Bull World Health Organ. 1979;57(5):767–771. [PMC free article] [PubMed] [Google Scholar]
  3. Gönnert R., Andrews P. Praziquantel, a new board-spectrum antischistosomal agent. Z Parasitenkd. 1977 Jul 21;52(2):129–150. doi: 10.1007/BF00389899. [DOI] [PubMed] [Google Scholar]
  4. HOU P. C. The pathology of Clonorchis sinensis infestation of the liver. J Pathol Bacteriol. 1955 Jul;70(1):53–64. doi: 10.1002/path.1700700106. [DOI] [PubMed] [Google Scholar]
  5. HOU P. C. The relationship between primary carcinoma of the liver and infestation with Clonorchis sinensis. J Pathol Bacteriol. 1956 Jul;72(1):239–246. doi: 10.1002/path.1700720130. [DOI] [PubMed] [Google Scholar]
  6. Katz N., Rocha R. S., Chaves A. Preliminary trials with praziquantel in human infections due to Schistosoma mansoni. Bull World Health Organ. 1979;57(5):781–785. [PMC free article] [PubMed] [Google Scholar]
  7. Komiya Y. Clonorchis and clonorchiasis. Adv Parasitol. 1966;4:53–106. doi: 10.1016/s0065-308x(08)60448-0. [DOI] [PubMed] [Google Scholar]
  8. Lindes C. Intestinal parasites in Laotian refugees. J Fam Pract. 1979 Nov;9(5):819–822. [PubMed] [Google Scholar]
  9. Okuda K., Emura T., Morokuma K., Kojima S., Yokagawa M. Clonorchiasis studied by percutaneous cholangiography, and a therapeutic trial of toluene-2,4-diisothiocyanate. A case report. Gastroenterology. 1973 Sep;65(3):457–461. [PubMed] [Google Scholar]
  10. Pellegrino J., Lima-Costa F. F., Carlos M. A., Mello R. T. Experimental chemotherapy of schistosomiasis mansoni. XIII. Activity of praziquantel, an isoquinoline-pyrazino derivative, on mice, hamsters and Cebus monkeys. Z Parasitenkd. 1977 Jul 21;52(2):151–168. doi: 10.1007/BF00389900. [DOI] [PubMed] [Google Scholar]
  11. Rider J. A., Devereaux R. G., Moeller H. C. Clonorchiasis. Treatment with chloroquine phosphate. Gastroenterology. 1967 Feb;52(2):267–271. [PubMed] [Google Scholar]
  12. Rim H. J., Lyu K. S., Lee J. S., Joo K. H. Clinical evaluation of the therapeutic efficacy of praziquantel (Embay 8440) against Clonorchis sinensis infection in man. Ann Trop Med Parasitol. 1981 Feb;75(1):27–33. doi: 10.1080/00034983.1981.11687405. [DOI] [PubMed] [Google Scholar]
  13. Rim Han Jong, Park Chang Yoon, Lee Joon Sang, Joo Kyoung Hwan, Lyu Kwang Sa. Therapeutic Effects Of Praziquantel (Embay 8440) Against Hymenolepis Nana Infection. Kisaengchunghak Chapchi. 1978 Dec;16(2):82–87. doi: 10.3347/kjp.1978.16.2.82. [DOI] [PubMed] [Google Scholar]
  14. Rim Han Jong, Park Soo Bae, Lee Joon Sang, Joo Kyoung Hwan. Therapeutic Effects Of Praziquantel (Embay 8440) Against Taenia Solium Infection. Kisaengchunghak Chapchi. 1979 Jun;17(1):67–72. doi: 10.3347/kjp.1979.17.1.67. [DOI] [PubMed] [Google Scholar]
  15. Santos A. T., Blas B. L., Noseñas J. S., Portillo G. P., Ortega O. M., Hayashi M., Boehme K. Preliminary clinical trials with praziquantel in Schistosoma japonicum infections in the Philippines. Bull World Health Organ. 1979;57(5):793–799. [PMC free article] [PubMed] [Google Scholar]
  16. Schwartz D. A. Helminths in the induction of cancer: Opisthorchis viverrini, Clonorchis sinensis and cholangiocarcinoma. Trop Geogr Med. 1980 Jun;32(2):95–100. [PubMed] [Google Scholar]
  17. Seah S. K. Digenetic trematodes. Clin Gastroenterol. 1978 Jan;7(1):87–104. [PubMed] [Google Scholar]
  18. Thomas H., Gönnert R. The efficacy of praziquantel against cestodes in animals. Z Parasitenkd. 1977 Jul 21;52(2):117–127. doi: 10.1007/BF00389898. [DOI] [PubMed] [Google Scholar]
  19. Webbe G., James C. A comparison of the susceptibility to praziquantel of Schistosoma haematobium, S. japonicum, S. mansoni, S. intercalatum and S. mattheei im hamsters. Z Parasitenkd. 1977 Jul 21;52(2):169–177. doi: 10.1007/BF00389901. [DOI] [PubMed] [Google Scholar]
  20. Wiesenthal A. M., Nickels M. K., Hashimoto K. G., Endo T., Ehrhard H. B. Intestinal parasites in Southeast-Asian refugees. Prevalence in a community of Laotians. JAMA. 1980 Dec 5;244(22):2543–2544. doi: 10.1001/jama.1980.03310220041024. [DOI] [PubMed] [Google Scholar]
  21. Yangco B. G., Klein T. W., Deresinski S. C., Vickery A. C., Craig C. P. Flubendazole and mebendazole in the treatment of trichuriasis and other helminthiases. Clin Ther. 1981;4(4):285–290. [PubMed] [Google Scholar]
  22. Yokogawa M., Koyama H., Araki K., Kojima S., Ozu S., Aida C., Ogino Y., Tsumura D. Mass treatment of clonorchiasis sinensis with 1,4-bis-trichloromethylbenzol. II. Minimal effective dose. Z Tropenmed Parasitol. 1969 Dec;20(4):494–503. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES